Question from Deputy Ken O'Flynn - PQ 39197-26
Deputy O'Flynn asked about whether the treatment abroad scheme is currently subject to any formal risk assessment. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about whether the treatment abroad scheme is currently subject to any formal risk assessment. Read the HSE response.
Deputy O'Flynn asked about value-for-money assessment before approval of high-cost treatment abroad scheme referrals. Read the HSE response.
Deputy Clarke asked about the cost of progressing one clinical nurse specialist post to an advanced nurse practitioner post. Read the HSE response.
Deputy Ó Murchú asked about the number of registrars in rheumatology based at the Mater Hospital. Read the HSE response.
Deputy Ward asked about the number of dietician hours delivered in 2025 and the cost of this. Read the HSE response.
Deputy Quaide asked about the number of children living in residential care more than 50km or 100km from home. Read the HSE response.
Deputy O'Flynn asked if any comparative analysis of orphan drug reimbursement timelines and approval rates against comparable European jurisdictions.
Deputy O'Flynn asked about the Treatment Abroad Scheme and clinical eligibility approval and financial expenditure approval. Read the HSE response.
Deputy O'Flynn asked if any reviews or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme.
Deputy O'Flynn asked about average cost of equivalent procedures between different EU/EEA healthcare systems under TAS. Read the HSE response.